Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Alexander Makarov Appointed as Professor of HR-MS at Utrecht University

Published: Wednesday, November 06, 2013
Last Updated: Wednesday, November 06, 2013
Bookmark and Share
Dr Alexander Makarov is the inventor of the Orbitrap mass analyzer, which changed the field of chemical analysis including proteomics.

The Executive Board of Utrecht University has appointed Dr. Alexander Makarov as Professor by Special Appointment of High Resolution Mass Spectrometry at the Department of Chemistry and the Bijvoet Center. Makarov is Director of Global Research for Life Sciences Mass Spectrometry at Thermo Fisher Scientific. His appointment is a further strengthening of the close research collaboration between Thermo Fisher Scientific and the Biomolecular Mass Spectrometry and Proteomics group of Prof. Albert Heck as well as a valuable strengthening in the education of Life Sciences students at the Faculty of Science.

Dr. Alexander Makarov

Physicist Alexander Makarov (1966), is the inventor of the Orbitrap mass analyzer, which changed the field of chemical analysis including proteomics, the analysis of proteins. Understanding protein function, in the context of health and disease research, is nowadays heavily reliant on proteomics. Since its introduction in 2005, Orbitrap-based mass spectrometers quickly conquered the research market and led to many breakthroughs in the field of physical, chemical and life sciences.

Bridge that connects academia and industry
The objective of the new chair is to research new applications to the analysis of large proteins and protein assemblies. This could allow detailed measurements of a range of biologically important species.

Makarov also looks forward to working closer with master and PhD students. “I hope that this appointment will become a bridge that connects academia and industry, allowing students as well as industrial scientists to reach across the divide and engage in mutual learning”. Through his appointment, students will get the opportunity to do part of their research at Thermo Fisher Scientific and learn about research in a company environment.

Bijvoet Center and Thermo Fisher Scientific
In the Bijvoet Center for Biomolecular Research, pharmacists, chemists and biologists perform research and offer a research training programme on the relation between the structure and function of biomolecules. The Center is one of the partners in Utrecht University’s Life Sciences programme, that focusses on ‘Public health, from molecule to population’.

Thermo Fisher Scientific Inc. is the world leader in serving science. It’s mission is to enable their customers to make the world healthier, cleaner and safer. With revenues of $13 billion, it has approximately 39,000 employees and serves customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. Thermo Fisher Scientific Inc. includes three premier brands, Thermo Scientific, Fisher Scientific and Unity Lab Services. 


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
The Need for Speed
Evaluating MALDI-TOF as a high-throughput screening technology for the pharmaceutical industry.
Antarctic Sponge Extract Kills MRSA
New findings may provide opportunity for developing new drugs to fight dangerous bacteria currently highly resistant to treatment.
US-India Collab Finds Molecular Signatures of Severe Malaria
Study may be a significant advancement in understanding the causes of severe malaria.
Novel Way to Prevent Deadly Bacterial Infections
Monash scientists may have found a way to stop deadly bacteria from infecting patients. The discovery could lead to a whole new way of treating antibiotic-resistant “superbugs”
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
An Old-New Weapon Against Emerging Chikungunya Virus
Researchers utilize existing drugs to interfere with host factors required for replication of Chikungunya virus.
Using Gene-editing Technology for Faster, Cheaper Antiviral Drug Development
UCLA scientists are working to develop special screening libraries based on a gene-editing technology called CRISPR.
Can Gender Play A Role In Determining Cancer Treatment Choices?
MD Anderson study reveals “sex-biased” gene signatures in review of 13 cancer types.
New Autism Blood Biomarker Identified
Researchers at UT Southwestern Medical Center have identified a blood biomarker that may aid in earlier diagnosis of children with autism spectrum disorder, or ASD.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!